99 related articles for article (PubMed ID: 16051303)
1. Characterization of antibody responses to purified HIV-1 gp120 glycoproteins fused with the molecular adjuvant C3d.
Koch M; Frazier J; Sodroski J; Wyatt R
Virology; 2005 Sep; 340(2):277-84. PubMed ID: 16051303
[TBL] [Abstract][Full Text] [Related]
2. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
Bower JF; Green TD; Ross TM
Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
[TBL] [Abstract][Full Text] [Related]
3. Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model.
Liu F; Mboudjeka I; Shen S; Chou TH; Wang S; Ross TM; Lu S
Vaccine; 2004 Apr; 22(13-14):1764-72. PubMed ID: 15068860
[TBL] [Abstract][Full Text] [Related]
4. Factors limiting the immunogenicity of HIV-1 gp120 envelope glycoproteins.
Grundner C; Pancera M; Kang JM; Koch M; Sodroski J; Wyatt R
Virology; 2004 Dec; 330(1):233-48. PubMed ID: 15527849
[TBL] [Abstract][Full Text] [Related]
5. Mouse strain-dependent differences in enhancement of immune responses by C3d.
Toapanta FR; Ross TM
Vaccine; 2004 Apr; 22(13-14):1773-81. PubMed ID: 15068861
[TBL] [Abstract][Full Text] [Related]
6. A minimum CR2 binding domain of C3d enhances immunity following vaccination.
Bower JF; Ross TM
Adv Exp Med Biol; 2006; 586():249-64. PubMed ID: 16893077
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d.
Green TD; Montefiori DC; Ross TM
J Virol; 2003 Feb; 77(3):2046-55. PubMed ID: 12525639
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Envgp140 trimers elicit neutralizing antibodies without efficient induction of conformational antibodies.
Bower JF; Li Y; Wyatt R; Ross TM
Vaccine; 2006 Jun; 24(26):5442-51. PubMed ID: 16621193
[TBL] [Abstract][Full Text] [Related]
9. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R
Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663
[TBL] [Abstract][Full Text] [Related]
10. Construction, expression and immunoassay detection of recombinant plasmid encoding fusion protein of Roman chicken complement C3d and Newcastle disease virus F gene.
Liu D; Niu ZX
Scand J Immunol; 2008 Dec; 68(6):598-606. PubMed ID: 19055698
[TBL] [Abstract][Full Text] [Related]
11. Genetic fusion of three tandem copies of murine C3d sequences to diphtheria toxin fragment B elicits a decreased fragment B-specific antibody response.
Gor DO; Ding X; Li Q; Greenspan NS
Immunol Lett; 2006 Jan; 102(1):38-49. PubMed ID: 16105692
[TBL] [Abstract][Full Text] [Related]
12. Immunization with an interferon-gamma-gp120 fusion protein induces enhanced immune responses to human immunodeficiency virus gp120.
McCormick AL; Thomas MS; Heath AW
J Infect Dis; 2001 Dec; 184(11):1423-30. PubMed ID: 11709784
[TBL] [Abstract][Full Text] [Related]
13. Assembly, structure, and antigenic properties of virus-like particles rich in HIV-1 envelope gp120.
Berkower I; Raymond M; Muller J; Spadaccini A; Aberdeen A
Virology; 2004 Mar; 321(1):75-86. PubMed ID: 15033567
[TBL] [Abstract][Full Text] [Related]
14. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
[TBL] [Abstract][Full Text] [Related]
15. Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers.
Goepfert PA; Tomaras GD; Horton H; Montefiori D; Ferrari G; Deers M; Voss G; Koutsoukos M; Pedneault L; Vandepapeliere P; McElrath MJ; Spearman P; Fuchs JD; Koblin BA; Blattner WA; Frey S; Baden LR; Harro C; Evans T;
Vaccine; 2007 Jan; 25(3):510-8. PubMed ID: 17049679
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of immune responses to an HIV gp120 DNA vaccine by fusion to TNF alpha cDNA.
Nimal S; Heath AW; Thomas MS
Vaccine; 2006 Apr; 24(16):3298-308. PubMed ID: 16464521
[TBL] [Abstract][Full Text] [Related]
17. C3d enhanced DNA vaccination induced humoral immune response to glycoprotein C of pseudorabies virus.
Tong T; Fan H; Tan Y; Xiao S; Ling J; Chen H; Guo A
Biochem Biophys Res Commun; 2006 Sep; 347(4):845-51. PubMed ID: 16857165
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
Jiang W; Ren L; Jin N
J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
[TBL] [Abstract][Full Text] [Related]
19. C3d enhances immune responses using low doses of DNA expressing the HIV-1 envelope from codon-optimized gene sequences.
Bower JF; Sanders KL; Ross TM
Curr HIV Res; 2005 Apr; 3(2):191-8. PubMed ID: 15853723
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of the circulating anti-HIV-1 gp120-specific B cell repertoire using antibody phage display libraries generated from pre-selected HIV-1 gp120 binding PBLs.
Koefoed K; Farnaes L; Wang M; Svejgaard A; Burton DR; Ditzel HJ
J Immunol Methods; 2005 Feb; 297(1-2):187-201. PubMed ID: 15777942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]